Evidence memo / Reproductive & endocrine

Corticorelin

Also: Acthrel · corticorelin ovine triflutate · CRH · corticotropin-releasing hormone

Corticorelin (Acthrel) is a synthetic copy of corticotropin-releasing hormone (CRH), the brain signal at the top of the body's stress-hormone axis. As an FDA-approved diagnostic, it is injected to test how the pituitary responds, helping doctors tell whether ACTH-dependent Cushing's syndrome comes from a pituitary tumor or from an ectopic source elsewhere. The Watchlist boundary is that it is a diagnostic, not a treatment.

Approved for specific usesApproved specific use

The verdict

Our read at a glance.

Whether corticorelin is understood as an approved diagnostic that probes the pituitary's ACTH response to help localize the source of Cushing's syndrome, rather than a treatment.

The signal
In the CRH stimulation test, corticorelin reliably triggers ACTH and cortisol release from the pituitary. Patients whose Cushing's comes from a pituitary tumor usually show an exaggerated response, while those with ectopic ACTH production usually do not, which helps point to the source, especially alongside specialized blood sampling.
The unknown
How its results are best combined with imaging and inferior petrosal sinus sampling for tricky cases, and the small overlap where the test can mislead, rather than whether it stimulates the pituitary.
Our read
A specialist diagnostic that pokes the top of the stress-hormone axis to localize the cause of Cushing's syndrome. Corticorelin reliably stimulates the pituitary, and the response pattern helps separate pituitary from ectopic ACTH sources; it is a testing tool, not a treatment.

The mechanism

How it works.

The body's stress-hormone system runs top-down: the hypothalamus releases corticotropin-releasing hormone (CRH), which tells the pituitary to release ACTH, which tells the adrenal glands to make cortisol. Corticorelin is a synthetic copy of CRH. Injected into a vein, it prompts the pituitary to release a burst of ACTH (and then cortisol), and the size and shape of that response helps tell apart the causes of ACTH-dependent Cushing's syndrome: a pituitary tumor usually over-responds, while an ACTH-producing tumor elsewhere in the body usually does not. It reads the axis rather than treating it.

Safety & regulatory boundary

The consequential part.

Corticorelin is generally well tolerated as a single diagnostic dose, with transient flushing the most common effect and occasional chest tightness or a drop in blood pressure. It is approved only as a diagnostic to help work up ACTH-dependent Cushing's syndrome, not as a treatment. Acthrel (synthetic ovine CRH) is given by a clinician in a specialist setting.

What's next

What we're watching.

Refinements in combining the CRH test with petrosal sinus sampling and imaging, and standardized response thresholds.

Context

Why this is discussed.

Corticorelin is lab-made CRH, the hormone that sits at the top of the stress axis: CRH tells the pituitary to release ACTH, which tells the adrenal glands to make cortisol. Doctors use it to figure out where excess ACTH is coming from when someone has Cushing's syndrome.

The evidence base

9 cited references.

Keep reading

Related published memos.